Anjali Advani, MD
Staff Physician in the Department of Hematologic Oncology and Blood Disorders and Director of the Inpatient Leukemia Program at the Taussig Cancer Institute at Cleveland Clinic- From ASH Meeting on Hematologic Malignancies: How would you treat relapsed/refractory myeloma after transplant?
Wednesday, September 11th, 2019
During their presentations, MHM speakers will be asking the audience how they would respond to patient cases. Audience members will vote live at the meeting via an audience response system, but we want to know what you would do.
- From ASH Meeting on Hematologic Malignancies: What are the approved options for relapsed marginal zone lymphoma?
Sunday, September 8th, 2019
During their presentations, MHM speakers will be asking the audience how they would respond to patient cases. Audience members will vote live at the meeting via an audience response system, but we want to know what you would do.
- From ASH Meeting on Hematologic Malignancies: How would you treat this patient with high-grade MDS?
Saturday, September 7th, 2019
During their presentations, MHM speakers will be asking the audience how they would respond to patient cases. Audience members will vote live at the meeting via an audience response system, but we want to know what you would do.
- How to Treat Ph-Negative Precursor B-Cell ALL and Ischemic Cardiomyopathy
Saturday, December 1st, 2018
This month, Anjali S. Advani, MD, discusses the management of Ph-negative ALL in a patient with ischemic cardiomyopathy. And don't forget to check out next month's clinical dilemma - send in your responses for a chance to win an ASH Clinical News-themed prize!
- From ASH Meeting on Hematologic Malignancies: Treating a Young Patient With Newly Diagnosed ALL
Monday, October 1st, 2018
During their presentations, MHM speakers will be asking the audience how they would respond to patient cases. Audience members will vote live at the meeting via an audience response system, but we want to know what you would do.
